New Insight Into Anti-Wrinkle Treatment: Using Nanoparticles as a Controlled Release System To Increase Acetyl Octapeptide-3 Efficiency

dc.contributor.author Bağlamış, Selami
dc.contributor.author Feyzioğlu-Demir, Esra
dc.contributor.author Akgöl, Sinan
dc.date.accessioned 2023-06-19T20:56:08Z
dc.date.available 2023-06-19T20:56:08Z
dc.date.issued 2023
dc.description.abstract Botulinum neurotoxins represent a revolution in cosmetic science because of their extraordinary and long-term anti-wrinkle properties. Nevertheless, high neurotoxicity severely limits their usage. Therefore, design and validation of new non-toxic molecules which mimics the Botox are needed. Here, acetyl octapeptide-3 is used which mimics the effect mechanism of botulinum neurotoxin to reduces the depth of wrinkles, was chosen as an alternative molecule. Glutamic acid containing poly(2-hydroxyethyl methacrylate-methacryloylamidoglutamic acid) [p(HEMAG)] nanoparticles were synthesized for controlled release of acetyl octapeptide-3 to increase the efficiency on the related area. Scanning electron microscopy and atomic force microscopy were used to state the morphological characteristics of the synthesized nanoparticles, and the Fourier transform infrared was used to characterize chemical structures; additionally, the dimensional analysis was carried out by using a zeta-sizer device, and then, characterized nanoparticles were used for loading acetyl octapeptide-3. Time, pH, ionic strength, temperature and concentration experiments were performed to optimize the adsorption conditions of the acetyl octapeptide-3 to the nanoparticles. The maximum acetyl octapeptide-3 adsorption capacity onto nanoparticles was found 220.69 mg/g. The pH and temperature experiments were carried out to follow-up the release conditions of acetyl octapeptide-3-loaded nanoparticles. Lastly, cytotoxicity tests were done by using Alamar Blue method and Lactate Dehydrogenase (LDH) Assay. Our results imply that the developed nanocosmetic material is non-toxic, efficient and cost-effective and it is promising to use in anti-wrinkle treatment. en_US
dc.description.sponsorship Ege University Scientific Research Projects Foundation; [16-FEN-006] en_US
dc.description.sponsorship AcknowledgementsThis project was supported by Ege University Scientific Research Projects Foundation (Project Number: 16-FEN-006). We thank Dr Aylin Sendemir and her group member for their helpful discussion and suggestions. en_US
dc.identifier.doi 10.1007/s00289-022-04663-8
dc.identifier.issn 0170-0839
dc.identifier.issn 1436-2449
dc.identifier.scopus 2-s2.0-85145749293
dc.identifier.uri https://doi.org/10.1007/s00289-022-04663-8
dc.identifier.uri https://hdl.handle.net/20.500.14365/4654
dc.language.iso en en_US
dc.publisher Springer en_US
dc.relation.ispartof Polymer Bulletin en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Acetyl octapeptide-3 en_US
dc.subject Anti-wrinkle en_US
dc.subject Bioactive peptide en_US
dc.subject Polymeric nanoparticles en_US
dc.subject Controlled release systems en_US
dc.subject Polymeric Nanoparticles en_US
dc.subject In-Vitro en_US
dc.subject Adsorption en_US
dc.subject Delivery en_US
dc.subject Protein en_US
dc.subject Cytotoxicity en_US
dc.subject Purification en_US
dc.subject Peptides en_US
dc.subject Kinetics en_US
dc.subject Efficacy en_US
dc.title New Insight Into Anti-Wrinkle Treatment: Using Nanoparticles as a Controlled Release System To Increase Acetyl Octapeptide-3 Efficiency en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id FEYZİOĞLU DEMİR, Esra/0000-0003-2012-4337
gdc.author.id Akgol, Sinan/0000-0002-8528-1854
gdc.author.institutional
gdc.author.wosid FEYZİOĞLU DEMİR, Esra/D-4575-2016
gdc.author.wosid Akgol, Sinan/H-9882-2014
gdc.bip.impulseclass C4
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Ekonomi Üniversitesi en_US
gdc.description.departmenttemp [Baglamis, Selami] Univ Amsterdam, Amsterdam UMC, LEXOR, Ctr Expt & Mol Med,Canc Ctr Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Baglamis, Selami] Univ Amsterdam, Oncode Inst, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Feyzioglu-Demir, Esra] Izmir Univ Econ, Vocat Sch Hlth Serv, Dept Med Lab Tech, TR-35330 Izmir, Turkiye; [Baglamis, Selami; Akgol, Sinan] Ege Univ, Fac Sci, Dept Biochem, TR-35100 Izmir, Turkiye; [Akgol, Sinan] Sabanci Univ, Nanotechnol Res & Applicat Ctr, TR-34956 Istanbul, Turkiye en_US
gdc.description.endpage 12681
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 12659
gdc.description.volume 80
gdc.description.wosquality Q2
gdc.identifier.openalex W4313681555
gdc.identifier.wos WOS:000910748800002
gdc.index.type WoS
gdc.index.type Scopus
gdc.oaire.accesstype HYBRID
gdc.oaire.diamondjournal false
gdc.oaire.impulse 6.0
gdc.oaire.influence 2.6120097E-9
gdc.oaire.isgreen false
gdc.oaire.keywords Efficacy
gdc.oaire.keywords Protein
gdc.oaire.keywords Cytotoxicity
gdc.oaire.keywords 500
gdc.oaire.keywords Anti-wrinkle
gdc.oaire.keywords 540
gdc.oaire.keywords Polymeric Nanoparticles
gdc.oaire.keywords 620
gdc.oaire.keywords Polymeric nanoparticles
gdc.oaire.keywords Bioactive peptide
gdc.oaire.keywords Kinetics
gdc.oaire.keywords In-Vitro
gdc.oaire.keywords Controlled release systems
gdc.oaire.keywords Acetyl octapeptide-3
gdc.oaire.keywords Adsorption
gdc.oaire.keywords Peptides
gdc.oaire.keywords Delivery
gdc.oaire.keywords Purification
gdc.oaire.popularity 5.7988268E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 0303 health sciences
gdc.oaire.sciencefields 03 medical and health sciences
gdc.openalex.collaboration International
gdc.openalex.fwci 0.7904
gdc.openalex.normalizedpercentile 0.66
gdc.opencitations.count 3
gdc.plumx.mendeley 10
gdc.plumx.newscount 1
gdc.plumx.scopuscites 6
gdc.scopus.citedcount 6
gdc.virtual.author Feyzioğlu Demir, Esra
gdc.wos.citedcount 6
relation.isAuthorOfPublication 3839aaca-de48-4539-915c-14beb011a113
relation.isAuthorOfPublication.latestForDiscovery 3839aaca-de48-4539-915c-14beb011a113
relation.isOrgUnitOfPublication d512834b-453f-4187-b56c-301bcee7dddc
relation.isOrgUnitOfPublication 102d99a4-5f52-4392-af31-1ecf89cc7516
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery d512834b-453f-4187-b56c-301bcee7dddc

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
3680.pdf
Size:
1.84 MB
Format:
Adobe Portable Document Format